Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in China
暂无分享,去创建一个
B. Han | Bo Jin | Xueyan Zhang | Huimin Wang | Y. Lou | Jianlin Xu | Yanwei Zhang | Hai-xia Yang | T. Chu | Dan Wu | Xue-Jun Dong | Xue Dong